REBECCA RIVARDO: Open Payments
NPI 1326237710 · HONESDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$792 in 49 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $708 · 2025 $792
Food & beverage: $792
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $163 |
| Madrigal Pharmaceuticals | 4 | $162 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $149 |
| Novo Nordisk Inc | 4 | $66 |
| Janssen Biotech, Inc. | 3 | $55 |
| Phathom Pharmaceuticals, Inc. | 6 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $20 |
| Celltrion USA Inc. | 1 | $16 |
Products named: REZDIFFRA, XIFAXAN, CREON, Wegovy, TREMFYA, VOQUEZNA, DUPIXENT, SKYRIZI.
Industry payments across PA — which companies pay providers there.
